ezetimibe has been researched along with Cardiac Hypertrophy in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiba, Y; Fukuda, K; Funahashi, A; Hashimoto, H; Katsuki, T; Kimura, M; Komuro, J; Kuoka, T; Kusumoto, D; Nakamura, T; Seki, T; Tokuoka, Y; Yamada, T; Yuasa, S | 1 |
| Chang, Y; Chen, YG; Ji, XP; Li, CB; Li, XX; Liu, BS; Xu, F; Zhang, C; Zhao, L | 1 |
| Fukuda, D; Hirata, Y; Kim-Kaneyama, JR; Kitagawa, T; Kurobe, H; Lei, XF; Masuzaki, H; Okawa, C; Sata, M; Sato, M; Shimabukuro, M; Soeki, T; Sugasawa, N; Takao, S; Tanaka, Y; Uematsu, E; Yagi, S; Yamada, H; Yanagi, S | 1 |
| Cramariuc, D; Gerdts, E; Rieck, AE; Tuseth, N; Wachtell, K | 1 |
| Acton, S; Braun, A; Broschat, KO; Krieger, M; Krul, ES; Napawan, N; Stagliano, N; Yesilaltay, A | 1 |
5 other study(ies) available for ezetimibe and Cardiac Hypertrophy
| Article | Year |
|---|---|
Development of non-bias phenotypic drug screening for cardiomyocyte hypertrophy by image segmentation using deep learning.
Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Cholesterol; Deep Learning; Drug Evaluation, Preclinical; Endothelin-1; Ezetimibe; Heart Failure; Mice; Myocytes, Cardiac; Rats | 2022 |
Ezetimibe prevents myocardial remodeling in an obese rat model by inhibiting inflammation.
Topics: Animals; Anticholesteremic Agents; Blotting, Western; C-Reactive Protein; Cardiomegaly; Collagen; Diet, High-Fat; Ezetimibe; Heart; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Myocardium; Obesity; p38 Mitogen-Activated Protein Kinases; Rats, Sprague-Dawley; Vascular Cell Adhesion Molecule-1; Ventricular Remodeling | 2018 |
The pathophysiological role of oxidized cholesterols in epicardial fat accumulation and cardiac dysfunction: a study in swine fed a high caloric diet with an inhibitor of intestinal cholesterol absorption, ezetimibe.
Topics: Adipose Tissue, White; Adiposity; Animals; Anticholesteremic Agents; Cardiomegaly; Cholesterol; Ezetimibe; Gastrointestinal Agents; Gene Expression Regulation, Enzymologic; Heart; Heart Diseases; Hydroxycholesterols; Hyperphagia; Intestinal Absorption; Lipoproteins, LDL; Liver; Male; Myocardium; Oxidation-Reduction; Pericardium; Random Allocation; Sus scrofa | 2016 |
Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy).
Topics: Aortic Valve Stenosis; Azetidines; Biomarkers; Cardiomegaly; Cardiomyopathy, Hypertrophic; Ezetimibe; Female; Heart Atria; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Simvastatin | 2010 |
Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins E; Azetidines; Bile Acids and Salts; Body Weight; Cardiomegaly; Cholesterol; Coronary Artery Disease; Cyclic N-Oxides; Disease Models, Animal; Eating; Ezetimibe; Female; Fibrosis; Hypercholesterolemia; Intestinal Absorption; Life Expectancy; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Scavenger Receptors, Class B; Survival Rate; Triglycerides; Tropanes | 2008 |